Literature DB >> 8897515

Malignant rhabdoid tumor in adults--heterogenous tumors with a unique morphological phenotype.

F J Leong1, A S Leong.   

Abstract

Five cases of malignant rhabdoid tumors in adult patients are described. The tumors were characterized by sheets of poorly cohesive cells with distinctive hyaline cytoplasmic inclusions and eccentrically placed large vesicular nuclei with prominent nucleoli. A variety of lineage differentiation was shown by immunohistochemistry and electron microscopy, the lesions representing leiomyosarcoma, gastric carcinoma, epithelioid sarcoma, Merkel cell carcinoma and desmoplastic small round cell tumor. Previously reported cases of rhabdoid tumors in adults support the contention that such tumors, although of distinctive morphologic phenotype, are of heterogenous lineage differentiation, and do not represent a distinct clinicopathologic entity.

Entities:  

Mesh:

Year:  1996        PMID: 8897515     DOI: 10.1016/S0344-0338(96)80053-7

Source DB:  PubMed          Journal:  Pathol Res Pract        ISSN: 0344-0338            Impact factor:   3.250


  4 in total

1.  Primary malignant rhabdoid tumor of greater omentum in 10-year-old girl.

Authors:  So-Hyun Nam; Jeong-A Park; Yeon Mee Kim
Journal:  Ann Surg Treat Res       Date:  2014-01-01       Impact factor: 1.859

Review 2.  Newer developments in immunohistology.

Authors:  A S-Y Leong; T Y-M Leong
Journal:  J Clin Pathol       Date:  2006-11       Impact factor: 3.411

3.  Malignant rhabdoid tumour of the liver in the young adult: report of first two cases.

Authors:  Ettore Marzano; Emilie Lermite; Cinzia Nobili; Carlos Teyssedou; Philippe Bachellier; Jean-Pierre Arnaud; Patrick Pessaux
Journal:  HPB Surg       Date:  2009-09-10

4.  Leiomyosarcoma with partial rhabdomyoblastic differentiation: first case report of primary cardiac origin.

Authors:  Yoichiro Okubo; Kazutoshi Shibuya; Atsushi Namiki; Kazuhisa Takamura; Noriaki Kameda; Tetsuo Nemoto; Aki Mitsuda; Megumi Wakayama; Minoru Shinozaki; Nobuyuki Hiruta; Kanako Kitahara; Takao Ishiwatari; Junichi Yamazaki
Journal:  BMC Cancer       Date:  2011-02-17       Impact factor: 4.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.